ATE201869T1 - 4-((thien-2-yl)methyl)imidazolderivate mit alpha2-adrenoceptor agonistischer aktivität - Google Patents
4-((thien-2-yl)methyl)imidazolderivate mit alpha2-adrenoceptor agonistischer aktivitätInfo
- Publication number
- ATE201869T1 ATE201869T1 AT97916963T AT97916963T ATE201869T1 AT E201869 T1 ATE201869 T1 AT E201869T1 AT 97916963 T AT97916963 T AT 97916963T AT 97916963 T AT97916963 T AT 97916963T AT E201869 T1 ATE201869 T1 AT E201869T1
- Authority
- AT
- Austria
- Prior art keywords
- methyl
- thien
- alpha2
- imidazole derivatives
- agonistic activity
- Prior art date
Links
- WJTRJFZWODRGDQ-UHFFFAOYSA-N 5-(thiophen-2-ylmethyl)-1h-imidazole Chemical class C=1C=CSC=1CC1=CNC=N1 WJTRJFZWODRGDQ-UHFFFAOYSA-N 0.000 title abstract 2
- 230000001270 agonistic effect Effects 0.000 title 1
- 108020004101 alpha-2 Adrenergic Receptor Proteins 0.000 title 1
- 102000015006 alpha2-adrenergic receptor activity proteins Human genes 0.000 title 1
- 239000001257 hydrogen Substances 0.000 abstract 4
- 229910052739 hydrogen Inorganic materials 0.000 abstract 4
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 abstract 2
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical group [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 abstract 2
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical group [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 abstract 2
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Chemical group BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 abstract 2
- 229910052794 bromium Inorganic materials 0.000 abstract 2
- 229910052801 chlorine Chemical group 0.000 abstract 2
- 239000000460 chlorine Chemical group 0.000 abstract 2
- 150000002431 hydrogen Chemical group 0.000 abstract 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
- 230000000202 analgesic effect Effects 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/625,447 US5621113A (en) | 1996-03-28 | 1996-03-28 | 4-[(thien-2-yl)methyl]-imidazole analgesics |
| PCT/US1997/004768 WO1997035857A1 (en) | 1996-03-28 | 1997-03-26 | 4-[(thien-2-yl)methyl]imidazole derivatives having alpha2-adrenoceptor agonistic activity |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE201869T1 true ATE201869T1 (de) | 2001-06-15 |
Family
ID=24506117
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT97916963T ATE201869T1 (de) | 1996-03-28 | 1997-03-26 | 4-((thien-2-yl)methyl)imidazolderivate mit alpha2-adrenoceptor agonistischer aktivität |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US5621113A (de) |
| EP (1) | EP0889891B1 (de) |
| JP (1) | JP4018145B2 (de) |
| AT (1) | ATE201869T1 (de) |
| AU (1) | AU718719B2 (de) |
| CA (1) | CA2250929C (de) |
| DE (1) | DE69705114T2 (de) |
| DK (1) | DK0889891T3 (de) |
| ES (1) | ES2159857T3 (de) |
| GR (1) | GR3036508T3 (de) |
| NO (1) | NO984482L (de) |
| NZ (1) | NZ332011A (de) |
| PT (1) | PT889891E (de) |
| TW (1) | TW382016B (de) |
| WO (1) | WO1997035857A1 (de) |
| ZA (1) | ZA972776B (de) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5750720A (en) * | 1996-03-28 | 1998-05-12 | Ortho Pharmaceutical Corporation | 4- (thien-3-yl)methyl!-imidazole analgesics |
| AU2002254265B2 (en) * | 1997-12-04 | 2008-05-15 | Allergan, Inc. | Imidiazole derivatives and their use as agonists selective at alpha 2B or 2B/2C adrenergic receptors |
| CN1284066A (zh) * | 1997-12-04 | 2001-02-14 | 阿勒根销售公司 | 对α2B或2B/2C肾上腺素能受体具有激动剂样活性的取代咪唑衍生物 |
| US6841684B2 (en) * | 1997-12-04 | 2005-01-11 | Allergan, Inc. | Imidiazoles having reduced side effects |
| US6329369B1 (en) | 1997-12-04 | 2001-12-11 | Allergan Sales, Inc. | Methods of treating pain and other conditions |
| US6426356B1 (en) | 1998-11-18 | 2002-07-30 | Ortho-Mcneil Pharmaceutical, Inc. | Imidazoethyl thiophenes |
| US6465486B1 (en) | 1999-03-12 | 2002-10-15 | Ortho-Mcneil Pharmaceutical, Inc. | Pyridyl/quinolinyl imidazoles |
| TWI283669B (en) * | 1999-06-10 | 2007-07-11 | Allergan Inc | Compounds and method of treatment having agonist-like activity selective at alpha 2B or 2B/2C adrenergic receptors |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FI894911A0 (fi) * | 1989-10-17 | 1989-10-17 | Farmos Oy | En terapeutiskt vaerdefull foerening. |
| CA2104873C (en) * | 1991-02-26 | 2000-05-23 | James N. Campbell | Compositions and methods of treatment of sympathetically maintained pain |
-
1996
- 1996-03-28 US US08/625,447 patent/US5621113A/en not_active Expired - Lifetime
-
1997
- 1997-03-26 DE DE69705114T patent/DE69705114T2/de not_active Expired - Lifetime
- 1997-03-26 AT AT97916963T patent/ATE201869T1/de active
- 1997-03-26 AU AU25440/97A patent/AU718719B2/en not_active Expired
- 1997-03-26 NZ NZ332011A patent/NZ332011A/en not_active IP Right Cessation
- 1997-03-26 ES ES97916963T patent/ES2159857T3/es not_active Expired - Lifetime
- 1997-03-26 CA CA002250929A patent/CA2250929C/en not_active Expired - Lifetime
- 1997-03-26 JP JP53454597A patent/JP4018145B2/ja not_active Expired - Lifetime
- 1997-03-26 EP EP97916963A patent/EP0889891B1/de not_active Expired - Lifetime
- 1997-03-26 DK DK97916963T patent/DK0889891T3/da active
- 1997-03-26 PT PT97916963T patent/PT889891E/pt unknown
- 1997-03-26 WO PCT/US1997/004768 patent/WO1997035857A1/en active IP Right Grant
- 1997-04-01 ZA ZA972776A patent/ZA972776B/xx unknown
- 1997-04-28 TW TW086105509A patent/TW382016B/zh not_active IP Right Cessation
-
1998
- 1998-09-25 NO NO984482A patent/NO984482L/no unknown
-
2001
- 2001-08-31 GR GR20010401368T patent/GR3036508T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP2000507548A (ja) | 2000-06-20 |
| CA2250929A1 (en) | 1997-10-02 |
| JP4018145B2 (ja) | 2007-12-05 |
| PT889891E (pt) | 2001-09-28 |
| AU718719B2 (en) | 2000-04-20 |
| NO984482D0 (no) | 1998-09-25 |
| ZA972776B (en) | 1998-10-01 |
| NO984482L (no) | 1998-11-24 |
| CA2250929C (en) | 2005-01-04 |
| NZ332011A (en) | 2000-02-28 |
| DE69705114D1 (de) | 2001-07-12 |
| EP0889891A1 (de) | 1999-01-13 |
| WO1997035857A1 (en) | 1997-10-02 |
| GR3036508T3 (en) | 2001-11-30 |
| DK0889891T3 (da) | 2001-09-03 |
| DE69705114T2 (de) | 2001-10-18 |
| AU2544097A (en) | 1997-10-17 |
| EP0889891B1 (de) | 2001-06-06 |
| TW382016B (en) | 2000-02-11 |
| US5621113A (en) | 1997-04-15 |
| ES2159857T3 (es) | 2001-10-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE228111T1 (de) | M-amidinophenyl-analoga als faktor-xa-inhibitoren | |
| PT935465E (pt) | Compostos novos de imidazole substituido | |
| DK1204654T3 (da) | Benzofurylpiperaziner og benzofurylhomopiperaziner: Serotonin agonister | |
| TR199700464A3 (tr) | Antihistaminik etkili yeni benzimidazole türevleri. | |
| BR9706973A (pt) | Novos compostos de imidazol substituídos | |
| ATE240321T1 (de) | 4- (thien-3-yl)methyl) imidazolderivate mit alpha2-adrenoceptor agonistischer aktivität | |
| TR200103353T2 (tr) | Bir füzyonlu heterosiklik bileşimin hidroklorid tuzu. | |
| DE69713402D1 (de) | Liganden des neuropeptids y | |
| TR199501387A2 (tr) | Alfa1-adrenerjik reseptör antagonistleri olarak, yeni £3-(4-fenilpiperazin-1-il) propilamino|-piridin, pirimidin ve benzen türevleri. | |
| SE9702773D0 (sv) | Novel compounds | |
| MX9203074A (es) | 4-(1h-pirrol-1-il)-imidazoles con actividad antagonista de angiotensina ii. | |
| IT1285770B1 (it) | Composti corticoidei | |
| ATE300543T1 (de) | Kondensierte pyrazindionderivate als pde5 inhibitore | |
| ATE258930T1 (de) | Dihydrobenzifurane | |
| ATE201869T1 (de) | 4-((thien-2-yl)methyl)imidazolderivate mit alpha2-adrenoceptor agonistischer aktivität | |
| DE60112960D1 (de) | Kondensierte pyridoindolderivate | |
| NO20033184D0 (no) | Anvendelse av forbindelsen (+)-<alfa>-(2,3-dimetoksyfenyl)-1- [2-(4-fluorfenyl)etyl]-4-piperidinmetanol | |
| DE60121048D1 (de) | PYRAZINOi1'2':1,6öPYRIDOi3,4-BöINDOLDERIVATE | |
| DE60122559D1 (de) | Indolderivate als pde5-inhibitoren | |
| NZ516620A (en) | 1,4-substituted 4,4-diaryl cyclohexanes | |
| DE69402935D1 (de) | Substituierte arylalkylaminobenzyl-aminopropanamide, ihre herstellung und verwendung als antiepileptische, neuroprotektive und antidepressive mittel | |
| ATE403422T1 (de) | Substituierte hydrazone als hemmer von cyclooxygenase-2 | |
| DE69828638D1 (de) | Hydroxam- und carbonsäurederivate mit mmp- und tnf-hemmender aktivität | |
| EA200200331A1 (ru) | Применение лептина для ингибирования пролиферации эндотелиальных клеток | |
| ATE215935T1 (de) | Heterozyklische verbidungen mit mmp und tnf inhibitorisher wirkung |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |